What are cannabinoids?

Cannabinoids are the naturally occurring chemical compounds found in the cannabis plant. Cannabinoids are responsible, in part, for the wide array of medicinal and psychoactive effects cannabis provides. There are over 110 known cannabinoids so far with studies continuing to reveal the complex molecular structures of the cannabis plant.

Cannabinoids interact with human physiology through the endocannabinoid system (ECS), the set of receptors that function to regulate health and promote homeostasis throughout the body, you can read more about the ECS on our website here. The ECS has two primary receptors, the CB1 and CB2. The CB1 receptor binds primarily to the brain and nervous system, while the CB2 receptor interacts largely with the immune system. The cannabis plant relies on cannabinoids binding to these receptors to produce the array of potential benefits and effects. Each cannabinoid holds unique characteristics of their own that are worth examining in order to maximize the desired effects from medical cannabis. Today we’re looking at the cannabinoid CBC or cannabichromene.


What is Cannabichromene?

Cannabichromene (CBC) is a non-psychoactive cannabinoid with a myriad of potential therapeutic applications. CBC may be an effective pain reliever, reduce inflammation, assist with digestive and gastrointestinal disorders, possess antibacterial and antifungal efficacy, and could potentially contribute to the regeneration of brain cells, which would make it especially useful in treating diseases such as multiple sclerosis, fibromyalgia, dementia, Alzheimer’s and other neurodegenerative conditions.

CBC is typically found in most cannabis strains in low levels and shares molecular similarity to cannabinoids THC and CBD. CBC is also a descendant of CBG, which acts a chemical precursor to these three major cannabinoids. Evidence suggests CBC may work most effectively when paired with other cannabinoids to maximize the whole plant spectrum medical cannabis has to offer.


How does CBC work?

CBC is considered to bind indirectly with the endocannabinoid system through stimulation of the body’s naturally occurring endocannabinoids – anandamide and 2-AG. CBC may also act as an agonist to the TRPV1 and TRPA1 receptors, which modulate pain sensitivity, body temperature, and inflammatory response. CBC is thought to bind with the CB1 and CB2 receptors but ongoing research is needed to clarify the complexity of this cannabinoid.

CBC shows the potential to deeply influence the benefits and effects of cannabis, particularly with its non-intoxicating properties. It could play a major role in cannabis-based medicine as a deeper understanding of cannabinoids and the ECS continues to evolve.


The Science

The antidepressant action of CBC and other cannabinoids was the focus of a 2010 study. Another 2010 study evaluated the anti-inflammatory properties of both CBC and THC, with impressive results when taken together. The pain relieving effects of CBC and CBD were examined in a 2011 study. The potential of CBC to modulate gastrointestinal motility was the subject of a 2012 study. And most impressive, a 2013 study suggests CBC may promote neurogenesis, showing promise for a variety of neurodegenerative disorders.

GreenLeaf Solutions is Bartlesville’s top rated cannabis dispensary and the only dispensary in NE Oklahoma that is owned and operated by licensed physicians. We take great pride in our award-winning cannabis flower, highest quality products, and the absolute best patient service. Any of our knowledgeable budtenders can answer you questions about cannabinoids and cannabis in general. We are open 10:00am to 7:00pm Monday through Saturday from. Drop in and see why we’re Bartlesville’s best cannabis dispensary!